Pharmaceutical company Charles River Laboratories has reached a settlement with activist investor Elliott Investment ...

Gilead Sciences announced $11 billion in new planned investment in the U.S. to boost its domestic manufacturing and research ...

Recent actions by President Donald Trump's administration, including staff cuts at the Food and Drug Administration, have ...

Federal health agencies will create a database of autism patients enrolled in Medicare and Medicaid that researchers will use ...

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts to discuss COVID-19 vaccine ...

Novo Nordisk reports its results in Danish kroner (DKK) rather than U.S. dollars. Sales grew 19% year over year to 78.1 ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

Novo Nordisk on Wednesday managed the unusual feat of seeing its stock price rise after reducing its earnings outlook. But ...

Novo Nordisk A/S NVO reported first-quarter 2025 earnings of 92 cents per American Depositary Receipt (ADR), which matched ...

U.S. Agriculture Secretary Brooke Rollins said during a hearing in the House of Representatives on Wednesday that new dietary ...

Eli Lilly won’t lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an ...